The End Fund Inc The END Fund's mission is to control and eliminate six neglected tropical diseases: river blindness, lymphatic filariasis, trachoma, schistosomiasis, intestinal worms, and visceral leishmaniasis.
Annual Revenue
$62,672,882
Known Funders
33
Grants Received
63
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $62,672,882 | $74,181,557 | $38,929,869 |
| 2023 | $56,392,358 | $64,042,913 | $50,403,877 |
| 2022 | $79,135,799 | $60,493,617 | $58,581,667 |
| 2021 | $35,034,243 | $36,973,338 | $37,486,570 |
| 2020 | $22,787,083 | $28,854,476 | $39,399,933 |
| 2019 | $44,978,754 | $31,011,608 | $45,414,106 |
| 2017 | $19,141,440 | $17,017,684 | $29,256,045 |
| 2016 | $17,665,991 | $16,109,756 | $27,069,526 |
Top Funders
NEW YORK, NY
JENKINTOWN, PA
JENKINTOWN, PA
SEATTLE, WA
SEATTLE, WA
NEW YORK, NY
NEW YORK, NY
SEATTLE, WA
SEATTLE, WA
SEATTLE, WA
Showing top 10 of 33 funders.
Key Personnel
From 2024 IRS 990 filing
SAMUEL MAYER
VP of Global Strategic Partnerships
MODUPEOLA ODUSOTE
Head of Culture & Talent
MIREILLE MATHER
VP of Investor Relations
ELLIE DEHGHAN
Head of Legal & Global Operations
CAROLINE KARUTU
VP of Programs
ELLEN AGLER
CEO thru June 15, 2024
DIANA BENTON SCHECHTER
COO / BOARD SECRETARY (thru June 15, 2024) INTERIM CEO (as of June 15, 2024)
ALAN MCCORMICK
VICE CHAIR
SCOTT POWELL
TREASURER (thru December 1, 2024)
Tsitsi Masiyiwa
CHAIR
Showing 10 of 15 key personnel.
Frequently Asked Questions
Other Nonprofits in New York
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.